I believe in investing for good reasons. Will never take a short position, will support companies that are trying to make a difference to the world we live in.
– – – – – – – – – – – – – – –
Starting September 2020, I’m trying to raise money for charity, follow my progress on twitter and on this site.
Currently heavily invested in the following :
Eurasia Mining (#EUA)
Novacyt (#NCYT)
Blue Star Capital (#BLU)
All Asia Asset Capital (#AAA)
Also have another 40 or so stocks in the portfolio, a fair old mix of disasters and soon to be triumphs. I’m also fairly active on Twitter
#SAL retail springing back into life.
You can currently book 2 days of #experientialspace at any @NetworkRail station🚉 for the price of 1! Valid for bookings that take place before 31.05.21.
@Spotlight_NR #brandexperience #brandactivation #networkrail #discount #prioritybooker
#CTNA #INSG Rto complete ✅ Name change to Insig AI ✅ Many congratulations and good luck to all invested📈
Test for travel system can’t cope with demand – even before the return of holidays https://www.which.co.uk/news/2021/04/test-for-travel-system-cant-cope-with-demand-even-before-the-return-of-holidays/
#ncyt #novacyt $alnov
Full confidence in @NovacytGroup to have foreseen the demand and to have scaled up accordingly 🔥🔥🔥🔥
Just rechecked the list...
Now 207 total approved suppliers and FORTY SIX are using either Nationwide Pathology or Biograd labs both which use #NCYT tests
Tip of the iceberg of the private testing market. Sit tight, be patient, and wait for Q3 revs to boom after travel opens https://twitter.com/BlackbirdInvest/status/1380796621487759363
#NCYT aren't lying when they say they are getting properly stuck in the private PCR testing market
Nationwide Pathology use none other than @PrimerdesignLtd for their Fit2Fly & Test to Release programmes..
...and they are also parter lab for a whopping SIXTEEN other suppliers!